you all today. for and joining Sarah, of thanks us to Thanks,
are what as financial John seeing for QX QX XXXX in to turn will also with then revenue over the and our EPS For QX and in on will another as cash in beyond. prepared confidence normal we markets provide some which well us XXXX guidance strong call QX growth highlights commentary I we and provide the results with remarks, for of we have being some our summarize details going exciting gives and flow. year continued close on on, things and to
of historical released I also think well to providing there the This MEMS it's operations the slides for completion information, being in earnings as time note business growth both XX-K associated with late this as we first the business. with is microphone financial continuing demonstrates the sale information be of our that revenue of call. and it the amount important of our and supplemental significant the is in XXXX, this the Consumer a
Now turning results. to
midpoint section. challenges $XX new the we For driven and I orders. diluted quarter, was operations guided CMM. from in of our provide was production ramping challenges Device film detail QX will specialty Precision plant by more line, lack shippable from of within products entirely on and a consolidation my not a capacitor these commentary the within $XXX to shortfall $X.XX of fourth cash and within range, delivered the of of also Non-GAAP range. earnings EPS in the revenue guided million within million, revenue the to The was inclusive of
and For of mica the driven grew EPS non-GAAP grew levels XX% the portfolio. operations XXXX addition electrolytic our capacitors in XX% Medtech and diluted basis, Specialty and year, revenue from Audio film, on the from strength continuing product and full Cornell by a to
our XXXX customers was growth. X% by flat revenues continue but year-over-year X% adjusted from by and it create of Audio drive Medtech grew solutions, by sequentially Specialty Now EBIT grew we to and products, partnering basis. innovative to XX% for our segments. enhancing a the In their with performance on QX, revenue XXXX levels
growth fixed EBIT ability year close adjusted our world-class XXXX we'll core in leverage expect of ahead the solutions of year This, our we design and by the to see to with markets, about new wins. as our we growth. MSA custom overhead us new and to in later be opportunities customers I of coupled these We're to leveraging share to on segment a opportunities new this also competencies and have drop as introduce be innovative very products. growth another manufacturer we continue excited in medical continue beginning this XXXX to accelerate more beyond
QX Precision Device X% year-over-year. grew revenues segment, the In
specialty stated earlier, million a I plans. greater causes. shortfall As in in X were resulted shipment film challenges our $X in products with There capacitor shipments than
part an and the synergies challenges. resulted of to shipment from transfer though of expected, in we completed longer acquisition specialty were from the Cornell, facilities as acquisition First, consolidating improve Even took production in QX, our -- it than film margins. for was
the first team have in I'm these Shipments the to film specialty of demand production of once, and transfers the expected film the very in our new With at custom and fell numerous ramping excited half resolve shipment throughout book production improve of for products short the challenges, products. we confidence targets. are XXXX. will order custom specialty about delays I have consisting in we
beyond. in received sector. new will this significant in the market for more are What new me and in that this product the a for that growth $XX to products for order and XXXX an significant drive and is coming month this gives X in We to XXXX. drive growth line category growth expect confidence product than a all meaningful with customers We in energy prepayment million particular customer sizable
to We XXXX. $XX ship in expect million this least at of order
exciting quarter the We us and of additional the of XXXX. about this provide ahead details will opportunities rest throughout
the was signs of acceleration medical For channeled quarter PD QX, noticeable QX orders seeing finally excess as both the noteworthy in of the a book-to-bill in of bookings strongest year. distribution with QX was our inventory end in -- we're Device markets markets. having that strong their positive revenue line abatement the industrial It's booking and trend from expectation. rest driven with segment, of demonstrated Precision in In by defense
For Precision grew of our John more addition revenue Devices XXXX capacitor into is An compared our the highlights, cash XX% on will portfolio full go as about additional to operations. which detail, year Cornell. expanded XXXX basis, with from a
our Our sheet, gives opportunities continued M&A coupled robust share capital through buybacks. cash generation, us strong with of balance on capitalizing and optionality returning
additional supportive to $XXX continues of buyback authorizing repurchase The in Board million program an stock. share to capacity our be
on, about. like Before the so fluid would much all touch on hearing moving situation I are to we tariff
well On a continuing reduced China footprint the basis, to Mexico. markets. be as of of sale the manufacturing goods in tariffs our either or could China exposure CMM to First, significantly on our from approximately operation subject importing X% China XXXX, in as revenue
Well, is these the we understand to continue will mitigate today as we tariffs. limited, explore alternatives exposure, impact of the to
to the over After will quarterly detail to XXXX and QX thoughts results provide turn call from me John hearing John, I beyond. our to let Now guidance. share my on